Biological agents for the treatment of rheumatic diseases have made a major breakthrough over the past decade.Since the discovery of adalimumab,a tumor necrosis factor(TNF)-α inhibitor,the rheumatoid arthritis therapy has been made significant progress.This article reviews related progress in the treatment of rheumatoid arthritis with adalimumab.